1-2 of 2
Vitaly Ablamunits
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade: Evidence of Improved Immune Regulation

Vitaly Ablamunits, Octavian Henegariu, Jakob Bondo Hansen, Lynn Opare-Addo, Paula Preston-Hurlburt, Pere Santamaria, Thomas Mandrup-Poulsen, Kevan C. Herold
Journal: Diabetes
Diabetes 2012;61(1):145–154
https://doi.org/10.2337/db11-1033
Published: 12 December 2011
View article titled, Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade: <subtitle>Evidence of Improved Immune Regulation</subtitle>
Open the PDF for Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade: <subtitle>Evidence of Improved Immune Regulation</subtitle> in another window
Includes: Supplementary data
Journal Articles

Hsp60 Peptide Therapy of NOD Mouse Diabetes Induces a Th2 Cytokine Burst and Downregulates Autoimmunity to Various β-Cell Antigens

Dana Elias, Aviram Meilin, Vitaly Ablamunits, Ohad S Birk, Pnina Carmi, Stephanie Könen-Waisman, Irun R Cohen
Journal: Diabetes
Diabetes 1997;46(5):758–765
https://doi.org/10.2337/diab.46.5.758
Published: 01 May 1997
View article titled, Hsp60 Peptide Therapy of NOD Mouse Diabetes Induces a Th2 Cytokine Burst and Downregulates Autoimmunity to Various β-Cell Antigens
Open the PDF for Hsp60 Peptide Therapy of NOD Mouse Diabetes Induces a Th2 Cytokine Burst and Downregulates Autoimmunity to Various β-Cell Antigens in another window